<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02930369</url>
  </required_header>
  <id_info>
    <org_study_id>DAILMP-CHINA</org_study_id>
    <nct_id>NCT02930369</nct_id>
  </id_info>
  <brief_title>Effects of Different Area of Internal Limiting Membrane Peeling (ILM) Peeling on Anatomical Outcomes in Macular Hole Surgery</brief_title>
  <official_title>A Randomized, Comparative, Prospective Study of Anatomical Outcomes With Different Internal Limiting Membrane Peeling Area in Surgery for Idiopathic Macular Hole</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University People's Hospital</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effects of two different internal limiting
      membrane (ILM) peeling area on anatomical closure outcomes after macular hole surgery
      measured by optical coherence tomography (OCT).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Anatomical closure grades in OCT</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of anatomical closure grades in OCT</measure>
    <time_frame>3 months, 6 months, 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in BCVA (best corrected visual acuity)</measure>
    <time_frame>3 months, 6 months, 1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">128</enrollment>
  <condition>Macular Hole</condition>
  <arm_group>
    <arm_group_label>4PD diameter of ILM peeling in surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients in this group was given 4papillary diameter (PD) diameter of internal limiting membrane (ILM) peeling in surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2PD diameter of ILM peeling in surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients in this group was given 2PD diameter of ILM peeling in surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ILM peeling surgery</intervention_name>
    <description>4PD or 2PD diameter of ILM peeling in surgery was given to patients with idiopathic macular hole (IMH)</description>
    <arm_group_label>4PD diameter of ILM peeling in surgery</arm_group_label>
    <arm_group_label>2PD diameter of ILM peeling in surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with IMH

          -  patients signed the informed consent form (ICF)

          -  patients with course of IMH less than 3 years

        Exclusion Criteria:

          -  patients with hyper myopia

          -  patients with traumatic macular hole

          -  accompanied or secondary of other fundus disease

          -  open or reopen after receiving MH surgery

          -  patients with retinal detachment

          -  received vitrectomy due to other diseases

          -  glaucoma cannot be controled by medication

          -  patients with other retinal or choroidal disease that may affect VA

          -  poor patients compliance

          -  poor condition that cannot undertake the surgery

          -  dioptric media opacities which make it difficult to exam fundus or measure on OCT
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mingwei Zhao, M.D</last_name>
    <role>Study Director</role>
    <affiliation>People's Hospital of Peking University</affiliation>
  </overall_official>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 10, 2016</study_first_submitted>
  <study_first_submitted_qc>October 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 12, 2016</study_first_posted>
  <last_update_submitted>October 11, 2016</last_update_submitted>
  <last_update_submitted_qc>October 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University People's Hospital</investigator_affiliation>
    <investigator_full_name>Mingwei Zhao</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Perforations</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

